Clinical Trial Update: A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas [Phase 2]

View source ↗

Summary

A Phase 2 prospective cohort study evaluating the effect of temozolomide on IDH-mutant low-grade gliomas (astrocytoma, oligodendroglioma, and oligoastrocytoma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Oligoastrocytoma
• Oligodendroglioma

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Huashan Hospital | Conditions: Astrocytoma, Oligodendroglioma | Phase 2 | Status: UNKNOWN